SCHEMBL754829

SCHEMBL754829

Cc1ccc2c(c1)sc1c3cc4sc5c6ccc(C)cc6sc5c4cc3sc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.44
MCL1 Q07820 1/20 0.44
MAPT P10636 7/20 0.38
RAB9A P51151 6/20 0.38
NPC1 O15118 5/20 0.38
LMNA P02545 2/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 2/20 0.35
CYP1A2 P05177 3/20 0.35
CYP2A6 P11509 3/20 0.35
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3123994 0.95 BCL2L1 (0.47) BCL2L1MCL1MAPTRAB9ANPC1
SCHEMBL12797652 0.94 BCL2L1 (0.41) BCL2L1MCL1MAPTRAB9ANPC1
SCHEMBL17037059 0.91 BCL2L1 (0.42) BCL2L1MCL1MAPTRAB9ANPC1
SCHEMBL11892121 0.91 BCL2L1 (0.44) BCL2L1MCL1MAPTRAB9ANPC1
SCHEMBL12796843 0.91 BCL2L1 (0.44) BCL2L1MCL1MAPTRAB9ANPC1
SCHEMBL16978710 0.90 BCL2L1 (0.41) BCL2L1MCL1MAPTRAB9ANPC1
SCHEMBL18252668 0.88 BCL2L1 (0.46) BCL2L1MCL1MAPTRAB9ANPC1
SCHEMBL12797655 0.87 CYP2A6 (0.45) BCL2L1MCL1MAPTRAB9ANPC1
SCHEMBL753610 0.86 PIM1 (0.40) BCL2L1MCL1MAPTRAB9AKDM4E
SCHEMBL12797651 0.86 BCL2L1 (0.36) BCL2L1MCL1MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME AS3MT, TERT, TEAD1 BCL2L1 1167/4885MCL1 935/4885MAPT 1194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.